Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current assets:    
Cash $ 6,498,035 $ 3,610,262
Accounts receivable - net 75,000 270,000
Marketable securities - available for sale securities 6,250 6,250
Prepaid expenses and other current assets 653,445 752,931
Total current assets 7,232,730 4,639,443
Other assets:    
Property and equipment, net 10,806 13,640
Intangible assets, net 19,533,517 6,157,659
Goodwill 2,227,488 2,144,488
Total other assets 21,771,811 8,315,787
Total Assets 29,004,541 12,955,230
Current liabilities:    
Accounts payable and accrued expenses 1,139,713 754,945
Notes payable 5,062,500   
Liabilities of discontinued operations 30,664 30,664
Total liabilities 6,232,877 785,609
Stockholders' Equity:    
Convertible Preferred stock Series A, $.0001 par value, 50,000,000 shares authorized: 1,023,579 and 0 issued and outstanding at June 30, 2014 and December 31, 2013, respectively 102   
Convertible Preferred stock Series B, $.0001 par value, 50,000,000 shares authorized: 391,000 and 0 issued and outstanding at June 30, 2014 and December 31, 2013, respectively 39   
Common stock, $.0001 par value; 200,000,000 shares authorized; 5,613,632 and 5,489,593 issued and outstanding at June 30, 2014 and December 31, 2013, respectively 561 549
Additional paid-in capital 32,598,618 22,673,287
Accumulated other comprehensive loss - marketable securities available for sale (6,250) (6,250)
Accumulated deficits (9,810,910) (10,487,469)
Total Marathon Patent Group, Inc. equity 22,782,160 12,180,117
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 22,771,664 12,169,621
Total liabilities and stockholders' equity $ 29,004,541 $ 12,955,230